Mirabella Financial Services LLP Buys 9,389 Shares of Amdocs Limited $DOX

Mirabella Financial Services LLP increased its stake in Amdocs Limited (NASDAQ:DOX) by 131.3% during the 2nd quarter, HoldingsChannel reports. The firm owned 16,540 shares of the technology company’s stock after buying an additional 9,389 shares during the period. Mirabella Financial Services LLP’s holdings in Amdocs were worth $1,509,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in DOX. Quarry LP boosted its stake in shares of Amdocs by 42.2% in the 1st quarter. Quarry LP now owns 391 shares of the technology company’s stock worth $36,000 after buying an additional 116 shares during the last quarter. Rossby Financial LCC purchased a new stake in Amdocs during the second quarter valued at $41,000. SVB Wealth LLC bought a new position in Amdocs in the first quarter valued at about $43,000. Caitong International Asset Management Co. Ltd boosted its position in Amdocs by 537.8% in the second quarter. Caitong International Asset Management Co. Ltd now owns 472 shares of the technology company’s stock worth $43,000 after purchasing an additional 398 shares during the last quarter. Finally, Neo Ivy Capital Management bought a new stake in shares of Amdocs during the 2nd quarter valued at about $54,000. 92.02% of the stock is currently owned by hedge funds and other institutional investors.

Amdocs Stock Performance

DOX stock opened at $76.45 on Friday. Amdocs Limited has a 1-year low of $74.32 and a 1-year high of $95.41. The business has a 50-day moving average price of $80.68 and a 200 day moving average price of $85.87. The company has a market capitalization of $8.63 billion, a P/E ratio of 15.14, a PEG ratio of 1.27 and a beta of 0.43. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.17 and a quick ratio of 1.22.

Amdocs (NASDAQ:DOX) last posted its earnings results on Tuesday, November 11th. The technology company reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.82 by $0.01. Amdocs had a net margin of 12.46% and a return on equity of 19.78%. The business had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter last year, the firm posted $1.70 EPS. The company’s revenue for the quarter was down 9.0% on a year-over-year basis. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS and its Q1 2026 guidance at 1.730-1.790 EPS. As a group, equities research analysts forecast that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be paid a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Wednesday, December 31st. Amdocs’s dividend payout ratio is 41.78%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a report on Thursday, November 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research report on Thursday, October 30th. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Stifel Nicolaus lowered their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Finally, Bank of America cut their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research report on Wednesday, November 12th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Amdocs presently has a consensus rating of “Moderate Buy” and an average price target of $97.00.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.